VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)

$0.258 0.0088 (3.5313%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 58

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) News Sources

VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Lags Revenue Estimates

12-02-2026

yahoo.com

external link

Vistagen Therapeutics Inc (VTGN) Q3 2026 Earnings Call Highlights: Progress in Clinical Trials ...

13-02-2026

yahoo.com

external link

VistaGen Therapeutics, Inc. Q3 2026 Earnings Call Summary

13-02-2026

moby.co

external link

Compugen (CGEN) Reports Q1 Loss, Lags Revenue Estimates

18-05-2026

yahoo.com

external link

Is Vistagen Therapeutics, Inc. (VTGN) a Breakout Anxiety Drug Stock After New Phase 3 Extension Results?

19-05-2026

yahoo.com

external link

Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Misses Revenue Estimates

20-05-2026

yahoo.com

external link

HealthEquity (HQY) Q1 Earnings and Revenues Top Estimates

28-05-2026

yahoo.com

external link

Vistagen Achieves Minimum ICH Safety Exposure Recommendations Across Clinical Program for Fasedienol for the Acute Treatment of Social Anxiety Disorder

09-06-2026

yahoo.com

external link

Vistagen Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

15-06-2026

yahoo.com

external link

Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder

30-06-2026

yahoo.com

external link

VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) Sentiment Trend

0 25 50 75 100 2 90 56 2 91 2 66 89 87 90 12-02-2026 13-02-2026 18-05-2026 19-05-2026 20-05-2026 28-05-2026 09-06-2026 15-06-2026 30-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) FAQs

toggle

What is the current price of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?

The current price of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is $0.258.


toggle

VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) absolute price change since previous trading day?

The absolute price change of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) since the previous trading day is $0.0088.


toggle

VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) percentage price change since previous trading day?

The percentage price change of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) since the previous trading day is 3.5313%.


toggle

What is the most recent average sentiment score for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?

The most recent average sentiment score for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is 58 out of 100.


toggle

What is the most recent average sentiment for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?

The most recent sentiment for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is .


SEC-8K** Filing Available For VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

VMD (Viemed Healthcare Inc)
VTRS (Viatris Inc)
VVOS (Vivos Therapeutics Inc)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.